Literature DB >> 23125302

Unusual manifestations of Epstein-Barr virus infection in an 8-month-old male infant.

Peninnah Oberdorfer1, Kritsana Kongthavonsakul, Taneeya Towiwat, Nutchanun Klangkalya.   

Abstract

Severe acute hepatitis is a rare complication of Epstein-Barr virus (EBV) infection. The authors report a case of an 8-month-old male infant who presented with subacute fever and jaundice. The physical examination showed hepatosplenomegaly and ecchymoses on his abdomen, chest wall and extremities. He received vitamin K therapy and prednisolone, and he recovered well without further complications or sequelae. Although severe acute hepatitis is a rare complication of EBV infection, clinicians should recognise this condition in order to provide a prompt treatment.

Entities:  

Mesh:

Year:  2012        PMID: 23125302      PMCID: PMC4544192          DOI: 10.1136/bcr-2012-007410

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

Review 1.  Acute complications of Epstein-Barr virus infectious mononucleosis.

Authors:  H B Jenson
Journal:  Curr Opin Pediatr       Date:  2000-06       Impact factor: 2.856

2.  Acute hepatitis: a rare complication of Epstein-Barr virus (EBV) infection.

Authors:  Mehmet Uluğ; Mustafa Kemal Celen; Celal Ayaz; Mehmet Faruk Geyik; Salih Hoşoğlu
Journal:  J Infect Dev Ctries       Date:  2010-10-28       Impact factor: 0.968

3.  Epstein Barr virus hepatitis.

Authors:  Diamantis P Kofteridis; Mairi Koulentaki; Antonios Valachis; Maria Christofaki; Elias Mazokopakis; George Papazoglou; George Samonis
Journal:  Eur J Intern Med       Date:  2010-08-19       Impact factor: 4.487

Review 4.  Epstein Barr virus hepatitis: case series and review.

Authors:  Nancy F Crum
Journal:  South Med J       Date:  2006-05       Impact factor: 0.954

5.  Acute hepatitis induced by Epstein-Barr virus infection: a case report.

Authors:  Ibrahim Doğan; Meltem Ergün; Mehmet Cindoruk; Selahattin Unal
Journal:  Turk J Gastroenterol       Date:  2007-06       Impact factor: 1.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.